Detailed Analysis of Temporal Features on Contrast Enhanced Ultrasound May Help Differentiate Intrahepatic Cholangiocarcinoma from Hepatocellular Carcinoma in Cirrhosis

被引:55
作者
Li, Rui [1 ]
Yuan, Meng-Xia [1 ]
Ma, Kuan-sheng [2 ]
Li, Xiao-Wu [2 ]
Tang, Chun-Lin [1 ]
Zhang, Xiao-Hang [1 ]
Guo, De-Yu [3 ]
Yan, Xiao-Chu [3 ]
机构
[1] Third Mil Med Univ, Southwest Hosp, Dept Ultrasound, Chongqing, Peoples R China
[2] Third Mil Med Univ, Southwest Hosp, Dept Hepatobiliary Pancreat Surg, Chongqing, Peoples R China
[3] Third Mil Med Univ, Southwest Hosp, Dept Pathol, Chongqing, Peoples R China
来源
PLOS ONE | 2014年 / 9卷 / 05期
关键词
CLINICAL-PRACTICE RECOMMENDATIONS; FOCAL LIVER-LESIONS; DIAGNOSTIC-ACCURACY; SURVEILLANCE; GUIDELINES; MISDIAGNOSIS; MANAGEMENT; RISK; CEUS; MRI;
D O I
10.1371/journal.pone.0098612
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Aim: To verify if detailed analysis of temporal enhancement patterns on contrast enhanced ultrasound (CEUS) may help differentiate intrahepatic cholangiocarcinoma (ICC) from hepatocellular carcinoma (HCC) in cirrhosis. Methods: Thirty three ICC and fifty HCC in cirrhosis were enrolled in this study. The contrast kinetics of ICC and HCC was analyzed and compared. Results: Statistical analysis did not reveal significant difference between ICC and HCC in the time of contrast first appearance and arterial peak maximum time. ICC displayed much earlier washout than that of HCC (47.93 +/- 26.45 seconds vs 90.86 +/- 31.26 seconds) in the portal phase, and most ICC (87.9%) showed washout before 60 seconds than HCC (16.0%). Much more ICC (78.8%) revealed marked washout than HCC (12.0%) while most HCC (88.0%) showed mild washout or no washout in late part of the portal phase (90-120 seconds). Twenty six out of thirty three ICC (78.8%) demonstrated both early washout(<60seconds) and marked washout in late part of the portal phase, whereas, only six of fifty HCC (12.0%) showed these temporal enhancement features (p = 0.000). When both early washout and marked washout in the portal phase are taken as diagnostic criterion for ICC, the diagnostic sensitivity, specificity, positive predictive value, negative predictive value and accuracy were 78.8%, 88.0%, 81.3%, 86.3%, and 84.3% respectively by CEUS. Conclusions: Analysis of detailed temporal enhancement features on CEUS is helpful differentiate ICC from HCC in cirrhosis. If a nodule in cirrhotic liver displays hyper-enhancement in the arterial phase followed by early and marked washout in the portal phase, the nodule is highly suspicious of ICC rather than HCC.
引用
收藏
页数:10
相关论文
共 28 条
  • [1] [Anonymous], 2011, HEPATOLOGY, V54, P1898
  • [2] Contrast enhanced ultrasound for the diagnosis of hepatocellular carcinoma (HCC): Comments on AASLD guidelines
    Barreiros, Ana Paula
    Piscaglia, Fabio
    Dietrich, Christoph F.
    [J]. JOURNAL OF HEPATOLOGY, 2012, 57 (04) : 930 - 932
  • [3] Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatment
    Blechacz, Boris
    Gores, Gregory J.
    [J]. HEPATOLOGY, 2008, 48 (01) : 308 - 321
  • [4] Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis
    Bolondi, L
    Sofia, S
    Siringo, S
    Gaiani, S
    Casali, A
    Zironi, G
    Piscaglia, F
    Gramantieri, L
    Zanetti, M
    Sherman, M
    [J]. GUT, 2001, 48 (02) : 251 - 259
  • [5] New perspectives for the use of contrast-enhanced liver ultrasound in clinical practice
    Bolondi, L.
    Correas, J. M.
    Lencioni, R.
    Weskott, H. P.
    Piscaglia, F.
    [J]. DIGESTIVE AND LIVER DISEASE, 2007, 39 (02) : 187 - 195
  • [6] Grading of hypervascular hepatocellular carcinoma using late phase of contrast enhanced sonography-A prospective study
    Boozari, Bita
    Soudah, Bisharah
    Rifai, Kinan
    Schneidewind, Sabine
    Vogel, Arndt
    Hecker, Hartmut
    Hahn, Andreas
    Schlue, Jerome
    Dietrich, Christoph F.
    Bahr, Matthias J.
    Kubicka, Stefan
    Manns, Michael P.
    Gebel, Michael
    [J]. DIGESTIVE AND LIVER DISEASE, 2011, 43 (06) : 484 - 490
  • [7] Management of hepatoceullular carcinoma
    Bruix, J
    Sherman, M
    [J]. HEPATOLOGY, 2005, 42 (05) : 1208 - 1236
  • [8] Management of Hepatocellular Carcinoma: An Update
    Bruix, Jordi
    Sherman, Morris
    [J]. HEPATOLOGY, 2011, 53 (03) : 1020 - 1022
  • [9] Intrahepatic cholangiocarcinoma and hepatocellular carcinoma: differential diagnosis with contrast-enhanced ultrasound
    Chen, Li-Da
    Xu, Hui-Xiong
    Xie, Xiao-Yan
    Xie, Xiao-Hua
    Xu, Zuo-Feng
    Liu, Guang-Jian
    Wang, Zhu
    Lin, Man-Xia
    Lu, Ming-De
    [J]. EUROPEAN RADIOLOGY, 2010, 20 (03) : 743 - 753
  • [10] Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) -: Update 2008
    Claudon, M.
    Cosgrove, D.
    Albrecht, T.
    Bolondi, L.
    Bosio, M.
    Calliada, F.
    Correas, J. -M.
    Darge, K.
    Dietrich, C.
    D'Onofrio, M.
    Evans, D. H.
    Filice, C.
    Greiner, L.
    Jaeger, K.
    de Jong, N.
    Leen, E.
    Lencioni, R.
    Lindsell, D.
    Martegani, A.
    Meairs, S.
    Nolsoe, C.
    Piscaglia, F.
    Ricci, P.
    Seidel, G.
    Skjoldbye, B.
    Solbiati, L.
    Thorelius, L.
    Tranquart, F.
    Weskott, H. P.
    Whittingham, T.
    [J]. ULTRASCHALL IN DER MEDIZIN, 2008, 29 (01): : 28 - 44